Govt wants to ease compliance burden on pharma industry: Mansukh MandaviyaStating that the industry plays an important role in nation-building and also in achieving self-reliance, the minister said that today the ...
Pharma companies seek govt nod to hike medicine pricesThe lobby group asked to allow prices of all scheduled formulations to be increased by 10% with immediate effect. Scheduled drugs are those...
Pharma lobby group backs granting of voluntary licenses by patent holders to Indian companies"Simple waiving of patents for vaccines is not enough for increased and free availability of Vaccines in India,” it said in a statement.The...
Chinese carrier Sichuan Airlines stopping flights may hit pharma imports, says industryCiting that the decision by the Chinese owned airlines suspending its cargo services to India for 15 days "worrisome", the Indian Drug Manu...
Modi's 'self-reliance' call need of the hour: Pharma industryDuring these unprecedented times, the pharmaceutical industry has worked with the government in an integrated manner and continued to opera...
'FSSAI order clears hurdle for nutraceutical product approval'FSSAI's recent notification on nutraceuticals will provide relief to health supplement manufacturers and marketers and clears all the hurdl...
Drug sector needs boost to reduce dependency on China: IDMAIDMA said the government should take necessary steps to give a boost to the domestic sector in order to reduce imports of API bulk drugs fr...
IDMA seeks exemptions for R&D, samplesIDMA expects that the weighted deduction of 200 % of R&D expenses in an in-house facility will be extended for further period of five years.
IDMA ties-up with UL to help pharma companies meet compliance levelsIDMA and global safety science company UL entered into an alliance for providing tools and training to domestic companies.
- IDMA breaks away from lobby of stockists and chemists
The Indian Drug Manufacturers' Association (IDMA) has ended its three decade-old trade agreement with a powerful lobby of stockists and che...
- Indian Drug Manufacturers Association wants anti-dumping duty to fend off Chinese competition
IDMA urged the govt to impose anti-dumping duties to counter unhealthy competition from China and sought inspection norms.
- Indian pharma sector will struggle without Govt support: IDMA
Indian companies would struggle to grab opportunities that would arise when almost $ 30-40 billion drugs become off-patented in the next 3-...
- Drugmakers ask government to allow FDI in pharma sector
The change of heart comes ahead of the release of a report by the panel set up to study a proposal to reduce the FDI in pharma sector from ...
- Is your doctor being bribed to suggest your drugs?
Delhi operation of a pharma co as earmarked an annual budget of Rs 2 crore for freebie for doctors in the Capital alone.
- Pharma industry seeks hike in medicine prices
Pharma companies have sought a hike in medicine prices and warned of stoppages in manufacturing of medicines under price controls, a top in...
- Idma seeks automatic licence system
THE Indian Drug Manufacturers' Association, in order to reap the full benefits of the Doha Agreement related to health and pharma, has dema...
IDMA urges for modified pricing policyTHE INDIAN Drug Manufacturers' Association has urged the government to expedite the introduction of the modified pricing policy on drugs.